Raily Aesthetic Medicine International Holdings Limited (HKG:2135)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1180
-0.0010 (-0.84%)
Sep 21, 2026, 3:58 PM HKT

HKG:2135 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
219.59189.41199.34189.38164.52188.37
Revenue Growth
15.93%-4.98%5.26%15.11%-12.66%14.48%
Gross Profit
92.6577.7171.4171.4966.7869.69
Operating Income
18.665.18-18.87-22.52-20.39-19.57
Net Income
13.541.87-59.21-32.46-15.91-17.69
Earnings Per Share
0.020.00-0.11-0.08-0.04-0.04
EPS Growth
622.93%-----

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Aesthetic Medical Services
156.25152.91142.1174.91151.66183.71
Aesthetic medical device products
64.0339.2659.0815.2214.211.65
Consulting Services
3.473.670.03-0.033.17
Elimination of Intersegment Sales
-4.16-6.43-1.87-0.75-1.38-0.17
Total
219.59189.41199.34189.38164.52188.37

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
48.6757.7928.8739.7978.78124.89
Total Debt
49.8559.1556.3751.7848.2267.45
Net Cash (Debt)
-1.17-1.36-27.5-11.9930.5657.44
Net Cash Growth
-----46.80%-56.88%
Net Cash Per Share
-0.00-0.00-0.05-0.030.070.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
29.4236.716.018.02-2.28-2.47
Capital Expenditures
-25.84-2.73-8.64-18-18.85-15.77
Free Cash Flow
3.5833.98-2.64-9.98-21.13-18.23
Free Cash Flow Growth
-89.47%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.19%41.03%35.82%37.75%40.59%37.00%
Operating Margin
8.50%2.73%-9.47%-11.89%-12.39%-10.39%
Pretax Margin
6.18%0.01%-32.74%-18.49%-13.43%-12.18%
Profit Margin
6.17%0.99%-29.70%-17.14%-9.67%-9.39%
FCF Margin
1.63%17.94%-1.32%-5.27%-12.84%-9.68%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.2440.09----
P/FCF Ratio
16.052.21----
PS Ratio
0.260.400.280.961.762.67